Logo 20and 20tagline 20preview
Logo 20and 20tagline high 20resolution

SFA Therapeutics, Inc

A Major Advancement in Treating Chronic Inflammatory Diseases and Cancer

  • Stage Product In Development
  • Industry Biotechnology
  • Location Jenkintown, PA, US
  • Currency USD
  • Founded December 2016
  • Employees 5
  • Incorporation Type C-corp
  • Website sfatherapeutics.com

Company Summary

SFA Therapeutics is an early stage biotech with a novel immunomodulatory platform focused on chronic inflammatory diseases and oncogenesis. Our drugs modulate the immune system, controlling inflammation and cancer. Primary targets include autoimmune diseases like psoriasis, and liver diseases, like Hepatitis B, NASH, & liver cancer. Other potential targets are uveitis, CLL/AML, and CAR-T side effects. We are in Ph 1b. We plan to change Medicine.

Team

  • Bc830ec9 65ce 4ad0 b47f c4a299ae6c18
    Founder and CEO

    Experienced drug developer, with over 25 years of R&D experience, involvement in 33 approved NDAs and 12 medical devices.

  • World-class hepatitis expert

  • GI microbiome expert

Advisors

Previous Investors